| Product Code: ETC8553543 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Argatroban Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Argatroban Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Argatroban Market - Industry Life Cycle |
3.4 New Zealand Argatroban Market - Porter's Five Forces |
3.5 New Zealand Argatroban Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 New Zealand Argatroban Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 New Zealand Argatroban Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in New Zealand |
4.2.2 Growing adoption of anticoagulant therapy in the country |
4.2.3 Rising geriatric population requiring anticoagulation therapy |
4.3 Market Restraints |
4.3.1 Stringent regulatory approval process for new drugs |
4.3.2 Limited awareness among healthcare professionals about argatroban |
4.3.3 High cost associated with argatroban therapy |
5 New Zealand Argatroban Market Trends |
6 New Zealand Argatroban Market, By Types |
6.1 New Zealand Argatroban Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Argatroban Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 New Zealand Argatroban Market Revenues & Volume, By Argatroban Powder, 2021- 2031F |
6.1.4 New Zealand Argatroban Market Revenues & Volume, By Argatroban Injection, 2021- 2031F |
6.2 New Zealand Argatroban Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Argatroban Market Revenues & Volume, By Heparin-induced Thrombocytopenia (HIT), 2021- 2031F |
6.2.3 New Zealand Argatroban Market Revenues & Volume, By Percutaneous Coronary Intervention, 2021- 2031F |
6.2.4 New Zealand Argatroban Market Revenues & Volume, By Cerebral Arterial Thrombosis, 2021- 2031F |
6.2.5 New Zealand Argatroban Market Revenues & Volume, By Others, 2021- 2031F |
7 New Zealand Argatroban Market Import-Export Trade Statistics |
7.1 New Zealand Argatroban Market Export to Major Countries |
7.2 New Zealand Argatroban Market Imports from Major Countries |
8 New Zealand Argatroban Market Key Performance Indicators |
8.1 Number of clinical trials or studies being conducted on argatroban in New Zealand |
8.2 Adoption rate of argatroban compared to other anticoagulants in the market |
8.3 Patient adherence and compliance rates to argatroban therapy. |
9 New Zealand Argatroban Market - Opportunity Assessment |
9.1 New Zealand Argatroban Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 New Zealand Argatroban Market Opportunity Assessment, By Application, 2021 & 2031F |
10 New Zealand Argatroban Market - Competitive Landscape |
10.1 New Zealand Argatroban Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Argatroban Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |